Zobrazeno 1 - 10
of 1 067
pro vyhledávání: '"Vongs, A."'
Autor:
Martin, William J., Howard, Andrew D., Nargund, Ravi P., Austin, Christopher P., Guan, Xiaoming, Drisko, Jennifer, Cashen, Doreen, Sebhat, Iyassu, Patchett, Arthur A., Figueroa, David J., DiLella, Anthony G., Connolly, Brett M., Weinberg, David H., Tan, Carina P., Palyha, Oksana C., Pong, Sheng-Shung, MacNeil, Tanya, Rosenblum, Charles, Vongs, Aurawan, Tang, Rui, Yu, Hong, Sailer, Andreas W., Fong, Tung Ming, Huang, Cathy, Tota, Michael R., Chang, Ray S., Stearns, Ralph, Tamvakopoulos, Constantin, Christ, George, Drazen, Deborah L., Spar, Brian D., Nelson, Randy J., MacIntyre, D. Euan
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2002 Aug . 99(17), 11381-11386.
Externí odkaz:
https://www.jstor.org/stable/3059577
Autor:
Ponn Vongs Vaddey
Publikováno v:
International Encyclopedia of Comparative Law Online
Externí odkaz:
https://doi.org/10.1163/2589-4021_IECO_COM_01KHM
Autor:
Hua V Lin, Dunlu Chen, Zhu Shen, Lei Zhu, Xuesong Ouyang, Aurawan Vongs, Yanqing Kan, John M Levorse, Edward J Kowalik, Daphne M Szeto, Xiaorui Yao, Jianying Xiao, Shirley Chen, Jinqi Liu, Marga Garcia-Calvo, Myung K Shin, Shirly Pinto
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54480 (2013)
Diacylglycerol acyltransferase-1 (DGAT1) is a potential therapeutic target for treatment of obesity and related metabolic diseases. However, the degree of DGAT1 inhibition required for metabolic benefits is unclear. Here we show that partial DGAT1 de
Externí odkaz:
https://doaj.org/article/04d6fea951f2478297b3dfeed85ea767
Autor:
Ji, Ren-Lei1 (AUTHOR) rlj0027@auburn.edu, Jiang, Shan-Shan1 (AUTHOR) szj0083@auburn.edu, Kleinau, Gunnar2 (AUTHOR) gunnar.kleinau@charite.de, Scheerer, Patrick2 (AUTHOR) patrick.scheerer@charite.de, Tao, Ya-Xiong1 (AUTHOR) taoyaxi@auburn.edu
Publikováno v:
Biomolecules (2218-273X). Sep2024, Vol. 14 Issue 9, p1120. 15p.
Autor:
Khadka, Janardan1,2 (AUTHOR), Trishla, Vikas S.1 (AUTHOR), Sannidhi, Sasank1 (AUTHOR), Singiri, Jeevan R.1 (AUTHOR), Grandhi, Rohith1,3 (AUTHOR), Pesok, Anat1 (AUTHOR), Novoplansky, Nurit1 (AUTHOR), Adler-Agmon, Zachor1,4 (AUTHOR), Grafi, Gideon1 (AUTHOR) ggrafi@bgu.ac.il
Publikováno v:
BMC Plant Biology. 8/28/2024, Vol. 24 Issue 1, p1-14. 14p.
Autor:
Zhao, Ziyi1 (AUTHOR), Yang, Yuta1 (AUTHOR), Liu, Peiyao1 (AUTHOR) zhao.ziyi@foxmail.com, Yan, Taotao1 (AUTHOR), Li, Ran1 (AUTHOR), Pan, Chuanying1 (AUTHOR), Li, Yang1 (AUTHOR) yangli2001@nwsuaf.edu.cn, Lan, Xianyong1 (AUTHOR) yangli2001@nwsuaf.edu.cn
Publikováno v:
Animals (2076-2615). Aug2024, Vol. 14 Issue 15, p2207. 13p.
Autor:
Vongs, Aurawan, Kakutani, Tetsuji
Publikováno v:
Science. 6/25/1993, Vol. 260 Issue 5116, p1926. 3p. 3 Black and White Photographs, 2 Charts, 1 Graph.
Autor:
Doreen E. Cashen, Constantin Tamvakopoulos, Qianping Peng, William J. Martin, David H. Weinberg, Charles Rosenblum, Arthur A. Patchett, Tanya MacNeil, Patrick G. Pollard, Zhixiong Ye, Raman K. Bakshi, Ralph A. Stearns, Rubana N. Kalyani, Palucki Brenda, Joseph M. Metzger, Alison M. Strack, Lex H.T. Van der Ploeg, D. Euan MacIntyre, Iyassu K. Sebhat, Aurawan Vongs, Airu S. Chen, Ravi P. Nargund, Liangqin Guo, Matthew J. Wyvratt, Randy R. Miller, Rui Tang, Howard Y. Chen, Khaled J. Barakat
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 15:3501-3505
A novel isoquinuclidine containing selective melanocortin subtype-4 receptor small molecule agonist, 3 (RY764), is reported. Its in vivo characterization revealed mechanism-based food intake reduction and erectile activity augmentation in rodents.
Autor:
George A. Doss, Lex H.T. Van der Ploeg, Qianping Peng, Ravi P. Nargund, Charles Rosenblum, Randall R. Miller, Aurawan Vongs, Palucki Brenda, Tanya MacNeil, Ralph A. Stearns, Min K. Park, David H. Weinberg, Rui Tang, Arthur A. Patchett, Constantin Tamvakopoulos
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 15:1993-1996
We report the discovery and optimization of substituted 2-piperazinecarboxamides as potent and selective agonists of the melanocortin subtype-4 receptor. The 5- and 6-alkylated piperazine compounds exhibit low bioactivation potential as measured by c
Autor:
William J. Martin, D. Euan MacIntyre, Ravi P. Nargund, Rubana N. Kalyani, Rui Tang, George A. Doss, Min K. Park, Alison M. Strack, Erin McGowan, Joseph M. Metzger, Charles Rosenblum, Randall R. Miller, Palucki Brenda, Qianping Peng, Arthur A. Patchett, Ralph A. Stearns, Patrick G. Pollard, Lex H.T. Van der Ploeg, Iyassu K. Sebhat, Constantin Tamvakopoulos, Cherrie Shepherd, Aurawan Vongs, Tanya MacNeil, David H. Weinberg, Zhixiong Ye
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 15:171-175
We report the discovery and optimization of substituted 2-piperazinecarboxamides as potent and selective agonists of the melanocortin subtype-4 receptor. Further in vivo development of lead agonist, MB243, is disclosed.